Report Overview
Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Dermatology Drug market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Dermatology Drug market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Dermatology Drug market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Dermatology Drug products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Dermatology Drug products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Dermatology Drug market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Dermatology Drug development has been the leading industry trend of Dermatology Drug market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Dermatology Drug Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
External Use,Oral,Injection, Other |
| By Application Outlook |
Psoriasis,Skin Infections,Acne,Dermatitis,Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Johnson & Johnson,Bayer,Galderma,Bristol-Myers Squibb,Novartis,Pfizer,Merz Pharma,Bausch Health Companies Inc,LEO Pharma,GlaxoSmithKline |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Johnson & Johnson
- Bayer
- Galderma
- Bristol-Myers Squibb
- Novartis
- Pfizer
- Merz Pharma
- Bausch Health Companies Inc
- LEO Pharma
- GlaxoSmithKline
Dermatology Drug Market, By Type
- External Use
- Oral
- Injection
- Other
Dermatology Drug Market, By Application
- Psoriasis
- Skin Infections
- Acne
- Dermatitis
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table Of Contents
Table of Contents
Global Dermatology Drug Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Dermatology Drug Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Dermatology Drug Industry Overview
2.1 Global Dermatology Drug Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Dermatology Drug Global Import Market Analysis
2.1.2 Dermatology Drug Global Export Market Analysis
2.1.3 Dermatology Drug Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 External Use
2.2.2 Oral
2.2.3 Injection
2.3.2 Skin Infections
2.3.3 Acne
2.3.4 Dermatitis
2.3.5 Other
2.4.2 Global Dermatology Drug Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Dermatology Drug Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Dermatology Drug Manufacturer Market Share
2.4.5 Top 10 Dermatology Drug Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Dermatology Drug Market
2.4.7 Key Manufacturers Dermatology Drug Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Dermatology Drug Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Dermatology Drug Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Dermatology Drug Market Size Categorized by Regions
4.1 Global Dermatology Drug Revenue, Sales and Market Share by Regions
4.1.1 Global Dermatology Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dermatology Drug Revenue and Market Share by Regions (2015-2020)
4.2 Europe Dermatology Drug Sales and Growth Rate (2015-2020)
4.3 APAC Dermatology Drug Sales and Growth Rate (2015-2020)
4.4 North America Dermatology Drug Sales and Growth Rate (2015-2020)
4.5 South America Dermatology Drug Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Dermatology Drug Sales and Growth Rate (2015-2020)
5 Europe Dermatology Drug Market Size Categorized by Countries
5.1 Europe Dermatology Drug Sales, Revenue and Market Share by Countries
5.1.1 Europe Dermatology Drug Sales by Countries (2015-2020)
5.1.2 Europe Dermatology Drug Revenue by Countries (2015-2020)
5.1.3 Germany Dermatology Drug Sales and Growth Rate (2015-2020)
5.1.4 UK Dermatology Drug Sales and Growth Rate (2015-2020)
5.1.5 France Dermatology Drug Sales and Growth Rate (2015-2020)
5.1.6 Russia Dermatology Drug Sales and Growth Rate (2015-2020)
5.1.7 Italy Dermatology Drug Sales and Growth Rate (2015-2020)
5.1.8 Spain Dermatology Drug Sales and Growth Rate (2015-2020)
5.2 Europe Dermatology Drug Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Dermatology Drug Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Dermatology Drug Sales Market Share by Type (2015-2020)
5.3.2 Europe Dermatology Drug Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Dermatology Drug Sales Market Share by Application (2015-2020)
6 Asia-Pacific Dermatology Drug Market Size Categorized by Countries
6.1 Asia-Pacific Dermatology Drug Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Dermatology Drug Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Dermatology Drug Revenue by Countries (2015-2020)
6.1.3 China Dermatology Drug Sales and Growth Rate (2015-2020)
6.1.4 Japan Dermatology Drug Sales and Growth Rate (2015-2020)
6.1.5 Korea Dermatology Drug Sales and Growth Rate (2015-2020)
6.1.6 India Dermatology Drug Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Dermatology Drug Sales and Growth Rate (2015-2020)
6.1.8 Australia Dermatology Drug Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Dermatology Drug Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Dermatology Drug Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Dermatology Drug Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Dermatology Drug Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Dermatology Drug Sales and Market Share by Application (2015-2020)
7 North America Dermatology Drug Market Size Categorized by Countries
7.1 North America Dermatology Drug Sales, Revenue and Market Share by Countries
7.1.1 North America Dermatology Drug Sales by Countries (2015-2020)
7.1.2 North America Dermatology Drug Revenue by Countries (2015-2020)
7.1.3 United States Dermatology Drug Sales and Growth Rate (2015-2020)
7.1.4 Canada Dermatology Drug Sales and Growth Rate (2015-2020)
7.1.5 Mexico Dermatology Drug Sales and Growth Rate (2015-2020)
7.2 North America Dermatology Drug Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Dermatology Drug Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Dermatology Drug Sales Market Share by Type (2015-2020)
7.3.2 North America Dermatology Drug Revenue and Revenue Share by Type (2015-2020)
7.4 North America Dermatology Drug Sales Market Share by Application (2015-2020)
8 South America Dermatology Drug Market Size Categorized by Countries
8.1 South America Dermatology Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Dermatology Drug Sales by Countries (2015-2020)
8.1.2 South America Dermatology Drug Revenue by Countries (2015-2020)
8.1.3 Brazil Dermatology Drug Sales and Growth Rate (2015-2020)
8.2 South America Dermatology Drug Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Dermatology Drug Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Dermatology Drug Sales Market Share by Type (2015-2020)
8.3.2 South America Dermatology Drug Revenue and Revenue Share by Type (2015-2020)
8.4 South America Dermatology Drug Sales Market Share by Application (2015-2020)
9 Middle East and Africa Dermatology Drug Market Size Categorized by Countries
9.1 Middle East and Africa Dermatology Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Dermatology Drug Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Dermatology Drug Revenue by Countries (2015-2020)
9.1.3 GCC Countries Dermatology Drug Sales and Growth Rate (2015-2020)
9.1.4 Turkey Dermatology Drug Sales and Growth Rate (2015-2020)
9.1.5 Egypt Dermatology Drug Sales and Growth Rate (2015-2020)
9.1.6 South Africa Dermatology Drug Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Dermatology Drug Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Dermatology Drug Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Dermatology Drug Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Dermatology Drug Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Dermatology Drug Sales Market Share by Application (2015-2020)
10 Global Dermatology Drug Market Segment by Type
10.1 Global Dermatology Drug Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Dermatology Drug Sales and Market Share by Type (2015-2020)
10.1.2 Global Dermatology Drug Revenue and Market Share by Type (2015-2020)
10.2 External Use Sales Growth Rate and Price
10.2.1 Global External Use Sales Growth Rate (2015-2020)
10.2.2 Global External Use Price (2015-2020)
10.3 Oral Sales Growth Rate and Price
10.3.1 Global Oral Sales Growth Rate (2015-2020)
10.3.2 Global Oral Price (2015-2020)
10.4 Injection Sales Growth Rate and Price
10.4.1 Global Injection Sales Growth Rate (2015-2020)
10.4.2 Global Injection Price (2015-2020)
11.1 Global Dermatology DrugSales Market Share by Application (2015-2020)
11.2 Psoriasis Sales Growth Rate (2015-2020)
11.3 Skin Infections Sales Growth Rate (2015-2020)
11.4 Acne Sales Growth Rate (2015-2020)
11.5 Dermatitis Sales Growth Rate (2015-2020)
11.6 Other Sales Growth Rate (2015-2020)
12.1 Global Dermatology Drug Revenue, Sales and Growth Rate (2020-2027)
12.2 Dermatology Drug Market Forecast by Regions (2020-2027)
12.2.1 Europe Dermatology Drug Market Forecast (2020-2027)
12.2.2 APAC Dermatology Drug Market Forecast (2020-2027)
12.2.3 North America Dermatology Drug Market Forecast (2020-2027)
12.2.4 South America Dermatology Drug Market Forecast (2020-2027)
12.2.5 Middle East & Africa Dermatology Drug Market Forecast (2020-2027)
12.3 Dermatology Drug Market Forecast by Type (2020-2027)
12.3.1 Global Dermatology Drug Sales Forecast by Type (2020-2027)
12.3.2 Global Dermatology Drug Market Share Forecast by Type (2020-2027)
12.4 Dermatology Drug Market Forecast by Application (2020-2027)
12.4.1 Global Dermatology Drug Sales Forecast by Application (2020-2027)
12.4.2 Global Dermatology Drug Market Share Forecast by Application (2020-2027)
13 Analysis of Dermatology Drug Industry Key Manufacturers
13.1 Johnson & Johnson
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Johnson & Johnson Dermatology Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Johnson & Johnson News
13.2 Bayer
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Bayer Dermatology Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Bayer News
13.3 Galderma
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Galderma Dermatology Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Galderma News
13.4 Bristol-Myers Squibb
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Bristol-Myers Squibb Dermatology Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Bristol-Myers Squibb News
13.5 Novartis
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Novartis Dermatology Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Novartis News
13.6 Pfizer
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Pfizer Dermatology Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Pfizer News
13.7 Merz Pharma
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Merz Pharma Dermatology Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Merz Pharma News
13.8 Bausch Health Companies Inc
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Bausch Health Companies Inc Dermatology Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Bausch Health Companies Inc News
13.9 LEO Pharma
13.9.1 Company Details
13.9.2 Product Information
13.9.3 LEO Pharma Dermatology Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 LEO Pharma News
13.10 GlaxoSmithKline
13.10.1 Company Details
13.10.2 Product Information
13.10.3 GlaxoSmithKline Dermatology Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 GlaxoSmithKline News
15 Appendix